California Man Convicted for Large-Scale Fentanyl Analogue Pill Mill Operation
For Immediate Release
U.S. Attorney's Office, District of New Jersey
TRENTON, N.J. – A California man was convicted today of conspiracy and manufacturing, distributing, and possessing with intent to manufacture and distribute a fentanyl analogue, Acting U.S. Attorney Rachael A. Honig announced.
Andrew Tablack, 29, of Beverly Hills, California, was convicted of one count of manufacturing, distributing, and possessing with intent to manufacture and distribute pills containing cyclopropyl fentanyl, an analogue of fentanyl intended for human consumption, in violation of the federal drug laws, and one count of conspiracy to do the same. The jury deliberated for less than two hours before returning the guilty verdict following a six-day trial before U.S. District Judge Michael A. Shipp in Trenton federal court.
According to documents filed in this case and the evidence at trial:
From at least March 2017 through December 2017, Tablack ran a massive pill making operation that distributed hundreds of thousands of fentanyl analogue pills throughout the United States, including New Jersey. These pills contained a powerful synthetic opioid with significant abuse potential. Tablack manufactured these illegal pills in clandestine labs in and near Los Angeles and sold them anonymously on the dark web, the Internet’s black market, using the moniker “XanaxKing2.” Tablack shipped approximately 400,000 of his illegal pills per month and made millions of dollars from his illegal operation in digital currency that is commonly used in the black market due to its relative anonymity.
Each count of the indictment is punishable by a maximum of 20 years in prison and a fine of $1 million. Sentencing is scheduled for Dec. 6, 2021.
This case was conducted under the auspices of the Organized Crime Drug Enforcement Task Force (OCDETF). The principal mission of the OCDETF program is to identify, disrupt and dismantle the most serious drug trafficking, weapons trafficking and money laundering organizations, and those primarily responsible for the nation’s illegal drug supply.
Acting U.S. Attorney Honig credited special agents with the Drug Enforcement Administration, Newark Division, under the direction of Special Agent in Charge Susan A. Gibson; the U.S. Department of Homeland Security, Homeland Security Investigation (HSI), Newark Division, under the direction of under the direction of Special Agent in Charge Jason J. Molina; inspectors of the U.S. Postal Inspection Service, under the direction of Acting Inspector in Charge Rodney M. Hopkins; and special agents of the U.S. Postal Service Office of Inspector General, under the direction of Special Agent in Charge Matthew Modafferi, Northeast Area Field Office, with the investigation leading to today’s guilty verdict.
The government is represented by Assistant U.S. Attorneys Tazneen Shahabuddin of the Special Prosecutions Division, José R. Almonte, Deputy Chief of the Criminal Division, and Sarah Devlin, Chief of the Asset Recovery and Money Laundering Unit.
Updated July 14, 2021